It is now more likely that the next graduate student you meet in the US is from one of two Chinese alma maters than from any other U.S. university?
The Slowing of Drug Discovery
The June 20th issue of Science had an interesting story worth noting (interesting to anyone into molecular pharmacology, anyway), on Drugs, Industry, and Academia. It caught my attention because of some conversations that I’ve been having recently with colleagues and friends in the industry – how is Big Pharma going to maintain itself amid slowing [...]